Dr.Aesha Desai, A21419
Aim:To determine the efficacy of prophylactic intracameral moxifloxacin 0.5%ophthalmic solution in preventing postop endophthalmitis after cataract surgery.Methods:The study was conducted from feb 2017 to april 2018. Preop and final 1-mnth postop anterior chamber reaction was assessed in 325 eyes that had received 0.1 mL intracameral moxifloxacin 0.5%(500 mg) after cataract surgery. Patients were followed up for 1 mnth. Patients with any introp complication or lost to follow-up were excluded.Results:308 eyes completed the study.The mean age was 69.5 yrs.All eyes had quiet ant. chamber preop and had trace to +2 cells and flare only on the 1st day after surgery. Pt evaluated on Day 1, Day 7 &after 1 month.There was no ant. chamber reaction and no endopthalmitis.Conclusion:Intracameral moxifloxacin appeared to be effective in preventing postop
ant. chamber reaction and ultimately endophthalmitis in patients undergoing cataract surgery.
Key words: intracameral moxifloxacin, cataract
Leave a Comment